In this video, Dr. Graham Belfield shares how the Discovery Science group at AstraZeneca is working to gather observational information from patient-derived material to better understand human disease and treatment and create predictive models that can reduce attrition in the clinic and ultimately develop more effective medicines that reach more patients.